Multimodal Strategy in Localized Merkel Cell Carcinoma: Where Are We and Where Are We Heading?

Multimodal Strategy in Localized Merkel Cell Carcinoma: Where Are We and Where Are We Heading?

Merkel cell carcinoma (MCC) is an aggressive neuroendocrine tumor of the skin whose incidence is rising. Multimodal treatment is crucial in the non-metastatic, potentially curable setting. However, the optimal management of patients with non-metastatic MCC is still unclear. In addition, novel insigh...

Full description

Bibliographic Details
Main Authors: Gianluca Ricco, Elisa Andrini, Giambattista Siepe, Cristina Mosconi, Valentina Ambrosini, Claudio Ricci, Riccardo Casadei, Davide Campana, Giuseppe Lamberti
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
Merkel cell carcinoma
surgery
radiotherapy
chemotherapy
immunotherapy
avelumab
Online Access:https://www.mdpi.com/1422-0067/22/19/10629

Internet

https://www.mdpi.com/1422-0067/22/19/10629

Similar Items